Industry introspects at Healthcare & Pharma Expansion Summit 2014
Regulatory reform, need for practical roll out of new guidelines were key concerns
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
’Indian pharma can use Ireland as a gateway to the global life sciences industry’
Brian Conroy, Director, Asia-Pacific, IDA Ireland reflects on the outcomes of the last delegation to India and outlines how Indian…
Interim budget disappoints pharma … yet again
Express Pharma presents industry reactions on the Interim Budget 2014
MSD and Cipla announce India-specific strategic partnership
To co-market MSD’s raltegravir 400 mg tablet, for Indian market
Jubilant Biosys expands drug discovery alliance with Janssen Pharmaceutica
Expansion will focus on discovering NCEs in multiple disease areas
Sun Pharma gets US FDA approval for generic Temodar Temozolomide capsules
Sun Pharmaceutical Industries announced that the US FDA has granted its subsidiary final approval for its abbreviated new drug…
IPM clocks Rs 6227 crores in Jan 2014
32 corporates have crossed the growth of IPM for January 2014 amongst top 50
FICCI with DoP to host The India Pharma Summit 2013-14
Federation of Indian Chambers of Commerce and Industry (FICCI) in partnership with Department of Pharmaceuticals, Ministry of…
Mumbai to host 2nd Edition of Healthcare & Pharma Expansion Summit
The 2nd Edition of Healthcare & Pharma Expansion Summit 2014 will be held in Mumbai on March 7, 2014
CII hosts round table with US FDA Commissioner
It was on 'Role, Opportunities and Challenges of Women in Indian Pharmaceutical and Food Industries’
’ACRO agenda is to minimise headwind, take advantage of tailwind’
D A Prasanna, Founder Chairman, Ecron Acunova has taken over as the Chairman of Association of Contract Research Organizations…
Buyouts to increase in consumer, pharma, tech sectors in 2014: KPMGs M&A Predictor
As Indian economy shows signs of bottoming out, analysts expect 2014 to be a much better year with increased M&A sentiment
Venus Remedies receives Indonesian GMP certification for its Baddi unit
The GMP approval will soon pave way for marketing authorisations from Indonesia; Venus expecting registrations for 10 oncology…
Mylan launches first trastuzumab biosimilar, Hertraz, in India
Its indicated for the treatment of HER2-positive metastatic breast cancer and is available in two strengths
Gilead names Mylan as exclusive branded medicines business partner for India
Under the agreement, Mylan will market and distribute in India certain Gilead medications
Pharmaceuticals exports to overtake domestic sales in FY15: Ind-Ra
Exports are likely to overtake domestic market sales in FY15, according to the rating agency
Generic opportunities in developed markets pivotal for Indian pharmas performance: ICRA
As far as the emerging markets are concerned certain regulatory developments in some of the markets have hindered the growth…
Venus Remedies bags US patent for Achnil
Developed by Venus Medicine Research Centre it will be commercialised in US market through technology transfer/outlicensing of…
SPARC gets DCGI nod for breast cancer injection paclitaxel
As a part of the arrangement, SPARC is eligible for milestone and royalty income